TTD | Drug: D0U1TA

Drug General Information
Drug ID	D0U1TA
Former ID	DIB009524
Drug Name	RHuEPO
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Approved	[546426], [551871]
Company	Bio-Gal Advanced Biotechnology
Target and Pathway
Target(s)	Erythropoietin Receptor	Target Info	Stimulator	[543465]
KEGG Pathway	Cytokine-cytokine receptor interaction
	PI3K-Akt signaling pathway
	Jak-STAT signaling pathway
	Hematopoietic cell lineage
NetPath Pathway	TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database	Signaling events mediated by Stem cell factor receptor (c-Kit)
Pathway Interaction Database	EPO signaling pathway
WikiPathways	EPO Receptor Signaling
References
Ref 546426	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008056)
Ref 551871	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 543465	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1718).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information